- Q1 2024 Cellectis SA Earnings Call TranscriptMay 29, 2024€2.4 (-8.40%)Earnings
- Q3 2023 Cellectis SA Earnings Call TranscriptNov 07, 2023€2.48 (-1.47%)Earnings
- Cellectis SA at Jefferies Cell & Genetic Medicine Summit TranscriptSep 26, 2023
- Q2 2023 Cellectis SA Earnings Call TranscriptAug 04, 2023€1.78 (-0.28%)Earnings
- Cellectis SA at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Q1 2023 Cellectis SA Earnings Call TranscriptMay 05, 2023€1.8 (+2.04%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Cellectis SA Earnings Call TranscriptMar 09, 2023€2.03 (-4.22%)Earnings
- Cellectis SA Corporate Analyst Meeting (Virtual) TranscriptDec 13, 2022
- Q3 2022 Cellectis SA Earnings Call TranscriptNov 04, 2022€2.4 (-5.10%)Earnings
- Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 Cellectis SA Earnings Call TranscriptAug 05, 2022€3.27 (+9.19%)Earnings
- Cellectis SA at Goldman Sachs Global Healthcare Conference TranscriptJun 16, 2022
- Cellectis SA at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 Cellectis SA Earnings Call TranscriptMay 13, 2022€2.96 (+0.85%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Cellectis SA Earnings Call TranscriptMar 04, 2022€3.43 (-4.14%)Earnings
- Cellectis SA at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Cellectis SA Earnings Call TranscriptNov 05, 2021€10.46 (+0.10%)Earnings
- Cellectis SA at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Cellectis SA Earnings Call TranscriptAug 06, 2021€11.88 (+2.19%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Cellectis SA Earnings Call TranscriptMar 05, 2021€14.44 (-13.27%)Earnings
- Cellectis SA at Barclays Virtual Gene Editing & Gene Therapy Summit - Presentation TranscriptNov 16, 2020
- Q3 2020 Cellectis SA Earnings Call TranscriptNov 06, 2020€14.11 (-4.14%)Earnings
- Cellectis SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Cellectis SA Earnings Call TranscriptAug 06, 2020€14.54 (-0.95%)Earnings
- Cellectis SA Chardan Leadership Call TranscriptMay 27, 2020
- Q1 2020 Cellectis SA Earnings Call TranscriptMay 07, 2020€12.86 (-0.46%)Earnings
- Q4 2019 Cellectis SA Earnings Call TranscriptMar 05, 2020€14 (-2.98%)Earnings
- Q3 2019 Cellectis SA Earnings Call TranscriptNov 07, 2019€11.53 (+1.45%)Earnings
- Cellectis SA at Citi Biotech Conference TranscriptSep 04, 2019
- Cellectis SA at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2019
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Cellectis SA Earnings Call TranscriptMar 12, 2019€16.23 (+2.33%)Earnings
Cellectis SA Chardan Leadership Call Transcript
Good morning, and good afternoon to call participants in Europe. Welcome to today's Chardan Leadership Call featuring Cellectis, a company focused on developing off-the-shelf T-cell therapies for cancers.
A special thank you to our guests today, Dr. André Choulika, CEO; Dr. Carrie Brownstein, CMO; and Simon Harnest, VP of Corporate Strategy and Finance, of Cellectis. So Cellectis is participating in this leadership call in conjunction with Chardan Cares, Chardan's fundraising initiative to support the programs and charities that are most important to the companies we work with. Chardan has made a donation to the Multiple Myeloma Research Foundation in Cellectis's name, and we encourage you to support this charity as well as you are able to. For more information, please reach out to our corporate access team.
I'm Geulah Livshits, a biotech analyst at Chardan. And as call participants are aware, our focus at Chardan is on identifying companies that can generate exceptionally high, long-term investment returns by creating and sharing in real
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)